Application 203969
- Type
- ANDA
- Sponsor
- TORRENT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 100MG | No | No |
| 002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 150MG | No | No |
| 003 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 200MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13668-430 | Bupropion hydrochloride | Bupropion hydrochloride | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-431 | Bupropion hydrochloride | Bupropion hydrochloride | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-431 | Bupropion hydrochloride | Bupropion hydrochloride | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-432 | Bupropion hydrochloride | Bupropion hydrochloride | Torrent Pharmaceuticals Limited | ANDA | Current |